ATE516044T1 - Attenuierte rotavirus-vakzine zur oralen verabreichung - Google Patents

Attenuierte rotavirus-vakzine zur oralen verabreichung

Info

Publication number
ATE516044T1
ATE516044T1 AT06707035T AT06707035T ATE516044T1 AT E516044 T1 ATE516044 T1 AT E516044T1 AT 06707035 T AT06707035 T AT 06707035T AT 06707035 T AT06707035 T AT 06707035T AT E516044 T1 ATE516044 T1 AT E516044T1
Authority
AT
Austria
Prior art keywords
oral administration
rotavirus vaccine
attenuated rotavirus
attenuated
vaccine
Prior art date
Application number
AT06707035T
Other languages
English (en)
Inventor
Velde Vincent Vande
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34385675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE516044(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE516044T1 publication Critical patent/ATE516044T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT06707035T 2005-02-17 2006-02-15 Attenuierte rotavirus-vakzine zur oralen verabreichung ATE516044T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0503337.8A GB0503337D0 (en) 2005-02-17 2005-02-17 Compositions
PCT/EP2006/001442 WO2006087205A1 (en) 2005-02-17 2006-02-15 Live attenuated rotavirus vaccine for oral administration

Publications (1)

Publication Number Publication Date
ATE516044T1 true ATE516044T1 (de) 2011-07-15

Family

ID=34385675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06707035T ATE516044T1 (de) 2005-02-17 2006-02-15 Attenuierte rotavirus-vakzine zur oralen verabreichung

Country Status (32)

Country Link
US (2) US8192747B2 (de)
EP (2) EP2322211A1 (de)
JP (1) JP5118977B2 (de)
KR (1) KR101319846B1 (de)
CN (2) CN103357005A (de)
AP (1) AP2692A (de)
AR (1) AR053680A1 (de)
AT (1) ATE516044T1 (de)
AU (1) AU2006215761B2 (de)
BR (1) BRPI0608877B8 (de)
CA (1) CA2598290C (de)
CY (1) CY1111916T1 (de)
DK (1) DK1863526T3 (de)
EA (1) EA012046B1 (de)
ES (1) ES2369246T3 (de)
GB (1) GB0503337D0 (de)
HR (1) HRP20110668T1 (de)
IL (1) IL184802A0 (de)
MA (1) MA29321B1 (de)
MX (1) MX2007010075A (de)
MY (1) MY145790A (de)
NO (1) NO341789B1 (de)
NZ (1) NZ560314A (de)
PE (1) PE20061094A1 (de)
PL (1) PL1863526T3 (de)
PT (1) PT1863526E (de)
SI (1) SI1863526T1 (de)
TW (1) TWI358303B (de)
UA (1) UA91044C2 (de)
UY (1) UY29377A1 (de)
WO (1) WO2006087205A1 (de)
ZA (1) ZA200706668B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101489587B (zh) * 2006-05-12 2015-05-27 伯哈拉特生物技术国际有限公司 一种可用作疫苗的组合物
WO2009042202A2 (en) * 2007-09-25 2009-04-02 Aridis Pharmaceuticals Formulations for preservation of rota virus
EP2236617A1 (de) 2009-03-31 2010-10-06 Leukocare Ag Verfahren zur Endsterilisierung von biofunktionalen Zusammensetzungen
CA3121471A1 (en) 2009-05-12 2010-11-18 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention New human rotavirus strains and vaccines
CN101972475B (zh) * 2010-04-12 2014-04-09 李建平 一种细菌多糖-蛋白结合疫苗及其制备方法
CN101863966B (zh) * 2010-05-21 2012-10-03 中国人民解放军第三军医大学 抗轮状病毒药物作用靶标及其构建方法和应用方法
EP3970715A1 (de) 2010-09-24 2022-03-23 University of Florida Research Foundation, Inc. Materialien und verfahren zur verbesserung der magen-darm-funktion
EP2471554A1 (de) * 2010-12-28 2012-07-04 Hexal AG Pharmazeutische Formulierung mit biopharmazeutischem Arzneimittel
WO2012103472A1 (en) * 2011-01-28 2012-08-02 Brian Pulliam Granularized particular thermostable rotovirus vaccine preparation
BR112013027457A2 (pt) * 2011-04-28 2019-09-24 Int Medica Foundation preparação de vacina, e, métodos de fabricar uma preparação de vacina, e de vacinar um mamífero
CN102349932B (zh) * 2011-10-12 2012-12-26 刘壮华 一种治疗息肉的药物制剂
WO2013105105A2 (en) * 2012-01-13 2013-07-18 Serum Institute Of India Ltd. Novel viral vaccine compositions and methods for preparing such vaccines
JP6084238B2 (ja) * 2012-02-08 2017-02-22 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 下痢を処置するための材料および方法
JP6253161B2 (ja) * 2012-03-05 2017-12-27 デ スタート デル ネーデルランデン， ヴェルト． ドール デ ミニステル ヴァン ヴイダブリューエス ミニステリー ヴァン ボルクスゲツォントヘイト， ベルジーン エン シュポルトＤｅ Ｓｔａａｔ Ｄｅｒ Ｎｅｄｅｒｌａｎｄｅｎ， Ｖｅｒｔ． Ｄｏｏｒ Ｄｅ Ｍｉｎｉｓｔｅｒ Ｖａｎ Ｖｗｓ Ｍｉｎｉｓｔｅｒｉｅ Ｖａｎ Ｖｏｌｋｓｇｅｚｏｎｄｈｅｉｄ， Ｗｅｌｚｉｊｎ Ｅｎ Ｓｐｏｒｔ 乾燥された生物学的材料を安定化するための方法及び組成物
WO2013160913A1 (en) * 2012-04-23 2013-10-31 Bharat Biotech International Limited Rotavirus vaccine compositions and process for preparing the same
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
CA2904046C (en) 2013-03-11 2020-01-14 University Of Florida Research Foundation, Incorporated Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
CN103316336B (zh) * 2013-05-31 2015-01-28 北京科兴中维生物技术有限公司 一种适于口服的轮状病毒疫苗
CN103316335B (zh) * 2013-05-31 2014-11-12 北京科兴生物制品有限公司 一种适于口服的脊髓灰质炎病毒疫苗
EP3021833B2 (de) * 2013-07-19 2022-03-30 Hexal Aktiengesellschaft Verfahren und formulierungen zur ermöglichung der modulation von immunreaktionen in zusammenhang mit der verabreichung eines biopharmazeutischen arzneimittels
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
US20160206728A1 (en) * 2013-10-03 2016-07-21 Nitto Denko Corporation Dried influenza vaccine preparation and method of producing the same
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
TWI670085B (zh) 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
CN113730564A (zh) * 2014-12-08 2021-12-03 武汉生物制品研究所有限责任公司 口服六价重配轮状病毒活疫苗
US10548970B2 (en) 2015-10-05 2020-02-04 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Human rotavirus G9P[6] strain and use as a vaccine
KR20180095817A (ko) * 2015-12-18 2018-08-28 머크 샤프 앤드 돔 코포레이션 열적으로 안정한 로타바이러스 백신 제제 및 그의 사용 방법
MA44557B1 (fr) 2016-06-16 2021-11-30 Bharat Biotech Int Ltd Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer
GB201614799D0 (en) * 2016-09-01 2016-10-19 Glaxosmithkline Biologicals Sa Compositions
BR112020021134A2 (pt) * 2018-04-16 2021-03-23 Merck Patent Gmbh aditivos para formulações de proteínas para aprimorar estabilidade térmica
CN110946871A (zh) * 2019-12-12 2020-04-03 浙江华康药业股份有限公司 槐糖在制备预防和治疗肥胖产品中的应用及对应产品
CN115531364B (zh) * 2021-06-30 2024-02-23 中国科学技术大学 预防或治疗轮状病毒感染的微生物代谢物制剂及其用途
CN113994925B (zh) * 2021-12-30 2022-04-26 北京赛尔富森生物科技有限公司 一种轮状病毒攻毒动物模型及其建立方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505657A1 (fr) 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
JP2849632B2 (ja) 1988-04-08 1999-01-20 社団法人北里研究所 ワクチン製剤
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
ES2121841T3 (es) * 1990-11-16 1998-12-16 Childrens Hosp Medical Center Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos.
NZ240818A (en) * 1990-12-14 1993-08-26 Mcneil Ppc Inc Liquid sucralose concentrate compositions containing preservative, buffer and liquid
EP0598037A1 (de) * 1991-08-05 1994-05-25 Sanofi Gepufferte peg-sod zusammensetzungen
CA2085827C (en) 1991-12-23 2003-10-14 Lucas A. T. Hilgers Adjuvant composition containing synthetic hydrophobic lipopolysaccharide
IT1253009B (it) 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
SK279188B6 (sk) 1992-06-25 1998-07-08 Smithkline Beecham Biologicals S.A. Vakcínová kompozícia spôsob jej prípravy a použiti
WO1994021292A1 (en) 1993-03-23 1994-09-29 Smithkline Beecham Biologicals (S.A.) Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
CN1055093C (zh) 1993-11-17 2000-08-02 实验室奥姆公司 葡糖胺二糖类、其制备方法和用途、以及含有这些二糖的药物组合物
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US6019982A (en) 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
GB9620795D0 (en) 1996-10-05 1996-11-20 Smithkline Beecham Plc Vaccines
DE69738271T2 (de) 1996-09-26 2008-08-28 Merck & Co., Inc. Rotavirus-impfstoff
US6403098B1 (en) * 1996-09-26 2002-06-11 Merck & Co., Inc. Rotavirus vaccine formulations
US6616931B1 (en) * 1996-09-26 2003-09-09 Merck & Co., Inc. Rotavirus vaccine formulations
US5932223A (en) * 1996-09-26 1999-08-03 Merck & Co., Inc. Rotavirus vaccine formulations
CN1259052A (zh) 1997-04-01 2000-07-05 科里克萨有限公司 单磷酰基脂质a的水性免疫佐剂组合物
WO1998056415A1 (en) 1997-06-11 1998-12-17 Aquila Biopharmaceuticals, Inc. Purified saponins as oral adjuvants
AU1145699A (en) 1997-09-05 1999-03-22 Smithkline Beecham Biologicals (Sa) Oil in water emulsions containing saponins
GB9718901D0 (en) 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
GB9725084D0 (en) * 1997-11-28 1998-01-28 Medeva Europ Ltd Vaccine compositions
US6919076B1 (en) * 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
EP1089913A1 (de) 1998-06-08 2001-04-11 SCA Emballage France Schnell zusammenklappbare verpackung aus karton
CZ302062B6 (cs) 1998-06-30 2010-09-22 Om Pharma Derivát acyldipeptidu, zpusob jeho prípravy, meziprodukty pro jeho prípravu a farmaceutický prostredek, který ho obsahuje
PT1212084E (pt) 1999-08-17 2006-07-31 Glaxosmithkline Biolog Sa Metodos para separar variantes do rotavirus e vacina do rotavirus vivo atenuado
AU1581400A (en) 1999-12-22 2001-07-03 Om Pharma Acyl pseudopeptides bearing a functionalised auxiliary spacer
EP1251869B1 (de) * 2000-01-28 2010-03-31 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen

Also Published As

Publication number Publication date
CA2598290A1 (en) 2006-08-24
EA200701519A1 (ru) 2008-02-28
PE20061094A1 (es) 2006-11-30
UY29377A1 (es) 2006-10-02
GB0503337D0 (en) 2005-03-23
CN101300028B (zh) 2014-06-04
KR20070103506A (ko) 2007-10-23
US20080166372A1 (en) 2008-07-10
AR053680A1 (es) 2007-05-16
CY1111916T1 (el) 2015-11-04
TW200640486A (en) 2006-12-01
TWI358303B (en) 2012-02-21
EP1863526B1 (de) 2011-07-13
NO20073868L (no) 2007-11-15
EP1863526A1 (de) 2007-12-12
HRP20110668T1 (hr) 2011-10-31
IL184802A0 (en) 2007-12-03
ZA200706668B (en) 2009-07-29
DK1863526T3 (da) 2011-10-24
MA29321B1 (fr) 2008-03-03
JP5118977B2 (ja) 2013-01-16
KR101319846B1 (ko) 2013-10-22
PT1863526E (pt) 2011-10-11
AU2006215761B2 (en) 2011-03-17
US8821891B2 (en) 2014-09-02
PL1863526T3 (pl) 2011-12-30
BRPI0608877B8 (pt) 2021-05-25
AU2006215761A1 (en) 2006-08-24
BRPI0608877A2 (pt) 2012-07-31
AP2692A (en) 2013-07-16
US20120237547A1 (en) 2012-09-20
UA91044C2 (uk) 2010-06-25
US8192747B2 (en) 2012-06-05
ES2369246T3 (es) 2011-11-28
EA012046B1 (ru) 2009-08-28
WO2006087205A1 (en) 2006-08-24
JP2008530165A (ja) 2008-08-07
CN101300028A (zh) 2008-11-05
NO341789B1 (no) 2018-01-22
BRPI0608877B1 (pt) 2021-02-09
AP2007004087A0 (en) 2007-08-31
CN103357005A (zh) 2013-10-23
EP2322211A1 (de) 2011-05-18
MX2007010075A (es) 2008-01-16
SI1863526T1 (sl) 2011-11-30
NZ560314A (en) 2011-02-25
CA2598290C (en) 2015-08-11
MY145790A (en) 2012-04-30

Similar Documents

Publication Publication Date Title
ATE516044T1 (de) Attenuierte rotavirus-vakzine zur oralen verabreichung
ATE516817T1 (de) Impfstoffe zur immunisierung gegen helicobacter
ATE462445T1 (de) Prrs-impfstoffe
ATE450271T1 (de) Impfstoff
DK1959991T3 (da) Terapeutisk vaccine
DK1968631T3 (da) Vaccine
MA28609B1 (fr) Vaccins
DK2066354T3 (da) Norovirus vaccine formuleringer
GB0607088D0 (en) Vaccine
ATE447991T1 (de) Arzneimittelabgabevorrichtung
MA28639B1 (fr) Vaccins
BRPI0719394A2 (pt) Preparação medicinal sólida
MA28885B1 (fr) vaccins
BRPI0607474A2 (pt) vacinação enriquecida com glicosido-alquila
EP2133092A4 (de) Oraler impfstoff
NO20100811A (no) Subenhetsvaksine for akvakutur
EP2075005A4 (de) Ipv-dpt-impfstoff
AP2695A (en) Vaccine adjuvants
UY3699Q (es) Dispositivo inhalador
ITMO20050210A1 (it) Dispositivo per tracheotomia
EP2054081A4 (de) Impfstoff gegen den jc-virus
EP1872794A4 (de) Nasale vakzine
GB0617602D0 (en) Vaccine
HK1115054A1 (en) Preparation for oral administration
FI20060582A0 (fi) Farmaseuttinen valmiste

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1863526

Country of ref document: EP